Skip to content

Author

L. Van Den Bosch

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Astrocytic Lipid Dysregulation in Amyotrophic Lateral Sclerosis

Although amyotrophic lateral sclerosis (ALS) has traditionally been viewed as a motor neuron-centered disease manifesting by muscle wasting and weakness, growing evidence indicates that disease progression is strongly influenced by interactions between motor neurons and surrounding glial cells. Astrocytes are major r...

W. S. Kim, H. Timmins, L. Van Den Bosch et al. · 0 citations
Open access Sep 2026

Data-driven identification of repurposable drugs for ALS

Amyotrophic lateral sclerosis (ALS) is a severe disease that causes thousands of deaths annually. Current treatments are either limited in effectiveness or not broadly applicable. To discover new options, we conducted a genetics-based screen to identify drugs that could be repurposed for ALS. We analyzed genome-wid...

S. Saez-Atienzar, Luis A. Rojas-Colón, Ruth Chia et al. · 0 citations
Open access Aug 2026

Early and Divergent Lipid Mediator Remodelling in Fast Versus Slow Skeletal Muscles of Female hSOD1G93A Mice

The findings identify the endocannabinoid system as an integral component of ALS muscle pathology and support skeletal muscle lipid signalling as a potentially relevant early target for adjunctive therapeutic strategies.

Sebastiaan Dalle, Kaat Vanderbeke, T. Burg et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.